Lesaka Technologies (LSAK) Proxy filing summary

Executive summary

• Annual meeting scheduled for November 18, 2026, in Johannesburg; record date September 25, 2026, with 85,794,723 common shares outstanding.

• Board recommends voting FOR all 11 director nominees, KPMG’s appointment for FY ending June 30, 2027, and the advisory executive-compensation proposal.

Voting matters and shareholder proposals

• Nine current directors stand for re-election and Carolina Lacerda and James Oates stand for election for one-year terms; Dean Sparrow resigned effective September 25, 2026.

• Director elections use plurality voting; KPMG ratification and say-on-pay pass if votes for exceed votes against. Abstentions and broker non-votes do not affect outcomes.

• Proposals for inclusion at the 2027 annual meeting, director nominations and other business are due June 8, 2027; proxy-solicitation notices for non-Board nominees are due September 19, 2027.

Board of directors and corporate governance

• Seven of 11 directors are Nasdaq-independent; all directors are elected annually, and the Board has no staggered terms, poison pill or supermajority voting requirements.

• Executive Chairman Ali Mazanderani leads operations and strategy; Lead Independent Director Kuben Pillay facilitates independent oversight, succession discussions and governance matters.

• The Board held five meetings in FY2026; directors attended all meetings during their service. Audit and Risk Committee held 12 meetings, Remuneration four, Nominating and Corporate Governance two, Social and Ethics three, and Capital Allocation four.

• Carolina Lacerda and James Oates joined the Board in September 2026; both were identified with a third-party search firm.

• Board committees oversee audit and risk, compensation, nominations and governance, social and ethics, and capital allocation, including acquisition execution and investment performance.